The genes that are well known as biomarkers for SLE patients, such as IFI44, IFI44L, and MX1, and that might be differential methylated only in LN patients, such as FGR, C17orf75, and HDAC4, were all validated in our samples [9–11]. The gene discussed is MX1; the disease is lobular neoplasia.